| PD-1 blockade in tumors with mismatch-repair deficiency DT Le, JN Uram, H Wang, BR Bartlett, H Kemberling, AD Eyring, ... New England Journal of Medicine 372 (26), 2509-2520, 2015 | 9452 | 2015 |
| Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade DT Le, JN Durham, KN Smith, H Wang, BR Bartlett, LK Aulakh, S Lu, ... Science 357 (6349), 409-413, 2017 | 5993 | 2017 |
| Detection of circulating tumor DNA in early-and late-stage human malignancies C Bettegowda, M Sausen, RJ Leary, I Kinde, Y Wang, N Agrawal, ... Science translational medicine 6 (224), 224ra24-224ra24, 2014 | 4680 | 2014 |
| Genetic diversity of tumors with mismatch repair deficiency influences anti–PD-1 immunotherapy response R Mandal, RM Samstein, KW Lee, JJ Havel, H Wang, C Krishna, ... Science 364 (6439), 485-491, 2019 | 439 | 2019 |
| The effect of preservative and temperature on the analysis of circulating tumor DNA S Parpart-Li, B Bartlett, M Popoli, V Adleff, L Tucker, R Steinberg, ... Clinical Cancer Research 23 (10), 2471-2477, 2017 | 186 | 2017 |
| Programmed death-1 blockade in mismatch repair deficient colorectal cancer DT Le, JN Uram, H Wang, B Bartlett, H Kemberling, A Eyring, NS Azad, ... J clin oncol 34 (15_suppl), 103, 2016 | 146 | 2016 |
| Noninvasive detection of microsatellite instability and high tumor mutation burden in cancer patients treated with PD-1 blockade A Georgiadis, JN Durham, LA Keefer, BR Bartlett, M Zielonka, D Murphy, ... Clinical Cancer Research 25 (23), 7024-7034, 2019 | 121 | 2019 |
| PD-1 blockade in mismatch repair deficient non-colorectal gastrointestinal cancers. DT Le, JN Uram, H Wang, H Kemberling, A Eyring, B Bartlett, ... Journal of Clinical Oncology 34 (4_suppl), 195-195, 2016 | 75 | 2016 |
| Detection of circulating tumor DNA in early-and late-stage human malignancies. Sci Transl Med. 2014; 6 (224): 224ra24 C Bettegowda, M Sausen, RJ Leary, I Kinde, Y Wang, N Agrawal, ... | 57 | 2014 |
| Detection of circulating tumor DNA in early-and late-stage human malignancies. Sci Transl Med. 2014; 6: 224ra24 C Bettegowda, M Sausen, RJ Leary, I Kinde, Y Wang, N Agrawal, ... | 54 | 2014 |
| Intratumoral adaptive immunosuppression and type 17 immunity in mismatch repair proficient colorectal tumors NJ Llosa, B Luber, AJ Tam, KN Smith, N Siegel, AH Awan, H Fan, T Oke, ... Clinical Cancer Research 25 (17), 5250-5259, 2019 | 52 | 2019 |
| Detection of circulating tumor DNA in early-and late-stage human malignancies. Sci Transl Med 6: 224ra24 C Bettegowda, M Sausen, RJ Leary, I Kinde, Y Wang, N Agrawal, ... | 50 | 2014 |
| Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1 KN Smith, NJ Llosa, TR Cottrell, N Siegel, H Fan, P Suri, HY Chan, H Guo, ... Journal for immunotherapy of cancer 7, 1-8, 2019 | 43 | 2019 |
| Programmed death-1 blockade in mismatch repair deficient cancer independent of tumor histology. LA Diaz, JN Uram, H Wang, B Bartlett, H Kemberling, A Eyring, NS Azad, ... Journal of Clinical Oncology 34 (15_suppl), 3003-3003, 2016 | 42 | 2016 |
| Immunopathologic stratification of colorectal cancer for checkpoint blockade immunotherapy NJ Llosa, B Luber, N Siegel, AH Awan, T Oke, Q Zhu, BR Bartlett, ... Cancer immunology research 7 (10), 1574-1579, 2019 | 38 | 2019 |
| Digital technology helps remove gender bias in academia J Fortin, B Bartlett, M Kantar, M Tseng, Z Mehrabi Scientometrics 126 (5), 4073-4081, 2021 | 17 | 2021 |
| The miRNA Profile of Inflammatory Colorectal Tumors Identify TGF-β as a Companion Target for Checkpoint Blockade Immunotherapy B Bartlett, Z Gao, M Schukking, M Menor, VS Khadka, M Fabbri, Y Deng Frontiers in Cell and Developmental Biology 9, 2757, 2021 | 5 | 2021 |
| Breeding and selection of taro (Colocasia esculenta) for improved disease‐resistance in Hawaiʻi R Paudel, B Bartlett, CM Zamora, JE Keach, R Gutierrez‐Coarite, ... Plants, People, Planet 5 (1), 123-145, 2023 | 3 | 2023 |
| la Chapelle de A DT Le, JN Uram, H Wang, BR Bartlett, H Kemberling, AD Eyring, ... Koshiji M, Bhaijee F, Huebner T, Hruban RH, Wood LD, Cuka N, Pardoll DM …, 2015 | 3 | 2015 |
| Circulating tumor DNA (ctDNA) as a prognostic marker for recurrence in resected pancreas cancer. JSZ Wang, M Sausen, S Parpart-Li, DM Murphy, VE Velculescu, LD Wood, ... Journal of Clinical Oncology 33 (15_suppl), 11025-11025, 2015 | 3 | 2015 |
Luis A. Diaz Jr.Memorial Sloan Kettering Cancer CenterVerified email at mskcc.org
